Trial · NCT07880340
Deep TMS for PTSD With Suicidal Ideation
NCT07880340, Not applicable, Not yet recruiting, D.R. Rut Zaks OHAYON
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Deep TMS for PTSD With Suicidal Ideation. Trials, record NCT07880340. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07880340
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Deep TMS for PTSD With Suicidal Ideation
- NCT number
- NCT07880340
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 72 participants, estimated
- Lead sponsor
- D.R. Rut Zaks OHAYON
- Conditions
- Post Traumatic Stress Disorder PTSD, Suicidal Ideation
- Interventions
- Deep Transcranial Magnetic Stimulation (DTMS)
- First posted
- 2026-10-19
- Last updated
- 2026-10-19
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Suicidal Ideation Scale | Screening, baseline, 2-week visits, post-treatment (4 weeks), and follow-up visits at 1 and 2 months | Change in suicidal ideation severity, measured by the Beck Scale for Suicidal Ideation (SSI). The total score ranges from 0 to 38. Higher scores indicate greater severity of suicidal ideation (worse outcome). |
| Secondary | PTSD Symptom Severity Scale | Screening, post-treatment (4 weeks), and follow-up at 1 and 2 months | Change in PTSD symptom severity measured by the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5). The total symptom severity score ranges from 0 to 80 (20 symptoms, each rated 0-4). Higher scores indicate greater severity (worse outcome). |
| Secondary | Self-Reported PTSD Symptoms Scale | Screening, baseline, 2-week visits, post-treatment (4 weeks), and follow-up visits at 1 and 2 months | Change in PTSD symptoms measured by the PTSD Checklist for DSM-5 (PCL-5). Total score ranges from 0 to 80 (20 items, each rated 0-4). Higher scores indicate greater severity (worse outcome). |
| Secondary | Depressive Symptoms scale | Screening, post-treatment (4 weeks), and follow-up visits at 1 and 2 months | Change in depressive symptoms measured by the Hamilton Depression Rating Scale (HDRS), 21-item version. Total score ranges from 0 to 52. Higher scores indicate greater severity of depression (worse outcome). |
| Secondary | Cognitive safety | Screening, post-treatment (4 weeks), and follow-up visits at 1 and 2 months | Change in cognitive performance measured by the Montreal Cognitive Assessment (MoCA). Total score ranges from 0 to 30. Higher scores indicate better cognitive performance (better outcome). A score of 26 or above is considered normal cognitive function. |
| Other | Neurophysiological Measure 1: Resting-state QEEG | Baseline, 2-week visits, post-treatment (4 weeks), and follow-up visits at 1 month | Change in resting-state quantitative EEG (QEEG), measured as the Z-score of band power in the theta band (4-8 Hz) at frontal sites. Z-scores are computed against a normative database; units are standard deviations (Z-scores). |
| Other | Neurophysiological Measure 2: TMS-evoked potentials (TEP) | Baseline, 2-week visits, post-treatment (4 weeks), and follow-up visits at 1 month | Change in the amplitude (microvolts; µV) of the TMS-evoked potential (TEP) components (P30, N45, P60, N100) at the stimulation site, recorded by EEG in response to single TMS pulses (TEP assessments) before the TMS treatment. |
| Other | Neurophysiological Measure 3: repeated TMS evoked potential | Baseline, 2-week visits, post-treatment (4 weeks), and follow-up visits at 1 month | Change in spectral power of the repetitive TMS-evoked potential (rTEP) at the stimulation site, recorded by EEG during high-frequency stimulation trains (the treatment itself). EEG data will be transformed to the frequency domain, and power will be computed in predefined frequency bands (theta, alpha, beta, low gamma). Units of measure: dB / percent change from baseline. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07880340
GET https://conductscience.org/api/trials/v1/NCT07880340/registered